#USA #Boston #LifeSphere #ArisGlobal #NavaX

ArisGlobal: Leading the Charge in Life Sciences Innovation

In an impressive display of growth and technological advancement, ArisGlobal, a prominent provider of AI solutions in the life sciences sector, reported significant achievements in 2025. The company, known for its flagship product, LifeSphere®, has solidified its reputation by launching innovative solutions and expanding its customer base. As organizations in the life sciences field grapple with mounting data volumes, complex regulatory pressures, and operational challenges, ArisGlobal has positioned itself at the forefront of addressing these needs.

Client Growth and AI Modernization

Throughout 2025, demand for AI-driven modernization surged as companies sought to enhance their IT and operational frameworks. ArisGlobal successfully attracted over 100 new clients while also expanding existing contracts within LifeSphere. In particular, the adoption of the NavaX platform saw a remarkable year-over-year increase of 125%, showcasing the growing confidence among clients in ArisGlobal's capabilities to deliver measurable outcomes. "Clients are no longer just experimenting with AI; they are integrating it into their core operations," stated Steve Nuckols, the company's customer success leader.

This momentum reflects a growing trend among organizations moving beyond initial pilot implementations to more expansive and complex use cases. As the life sciences sector shifts toward broader integrations of AI, ArisGlobal's commitment to delivering concrete results, such as faster turnaround times, consistency, and improved regulatory readiness, has proven to be indispensable.

Global Deployments at Scale

The year 2025 was marked by ArisGlobal achieving remarkable success in global deployments, including 38 launches. Their ability to execute complex programs at scale has reinforced their reputation in the industry. The breakdown of these efforts includes 22 security-related implementations, 11 regulatory rollouts, and 5 deployments of the NavaX system. Notably, ArisGlobal ventured into implementations for three of the world's top ten pharmaceutical companies, marking a first for advanced AI capabilities in production.

Raj Hattarki, the company's chief operating officer, emphasized the urgency with which ArisGlobal's teams approach project delivery, noting that their focus on compliance and foundational success for long-term engagement remains unchanged. "Every saved day in deployment translates into reduced time for our clients to generate impactful results," he added.

Product Innovation: From AI Functions to Intelligent Orchestration

In addition to impressive client growth, ArisGlobal made substantial strides in product innovation throughout 2025. LifeSphere has morphed from standalone AI functions to a more interconnected operational model, driven by intelligent orchestration. Some of the key launches included:

• - Unify: A data orchestration layer that integrates security, regulatory, quality, and medical data, providing a unified platform for visibility and decision-making across domains.
• - NavaX Insights: This tool transforms operational and safety data into actionable intelligence through real-time analytics, trend identification, and performance tracking.
• - NavaX Agents: The introduction of agent-based AI in safety and regulatory tasks that significantly enhances workflow efficiency.

In its current state, NavaX is processing approximately 700,000 cases annually, with projections suggesting this number could rise to 2.5 million by mid-2026. ArisGlobal's innovative leadership earned it the Frost & Sullivan 2025 New Product Innovation Award, and the company continues to play an active role in the EU's AI Pact, affirming its commitment to responsible AI practices in regulated environments.

Ann-Marie Orange, the company's global chief data officer and head of R&D, noted, "2025 marked a pivotal moment where AI transitioned from theory to delivering tangible results. With NavaX and Unify, clients are not just automating; they're orchestrating data and decisions enterprise-wide."

Looking Ahead

As 2026 unfolds, ArisGlobal is poised to amplify its role as a strategic partner in data intelligence and technology for global life sciences organizations. Driven by the progress made in the previous year, ArisGlobal's focus will be on scaling its enterprise AI capabilities and reinforcing its commitment to responsible AI implementations that cater to real-world operational requirements.

"This year has illustrated the potential of responsible AI implementation designed for genuine operations," stated Aman Wasan, CEO of ArisGlobal. \"With AI entering its enterprise phase, our emphasis will remain on intelligent orchestration, trust in design, and delivering impactful results for patients, regulators, and the teams that support them.\"

About ArisGlobal

Based in the United States, ArisGlobal is revolutionizing how some of today's leading life sciences companies develop innovations and bring new products to market through its AI-first technology approach and LifeSphere platform. With regional offices across Europe, India, Japan, and China, ArisGlobal is dedicated to enhancing operational efficiency and compliance in the ever-evolving life sciences landscape. For more information, follow ArisGlobal on LinkedIn or visit their website at www.arisglobal.com.